Louis Jacob1, Matthias Kalder2, Birgit Arabin2,3, Karel Kostev4. 1. Faculty of Medicine, University of Paris 5, Paris, France. 2. Department of Gynecology and Obstetrics, Philipps University of Marburg, Marburg, Germany. 3. Clara Angela Foundation Witten and Berlin, Witten, Berlin, Germany. 4. Epidemiology, Real World Evidence Solutions IMS Health, Darmstädter Landstraße 108, 60598, Frankfurt am Main, Germany. kkostev@de.imshealth.com.
Abstract
PURPOSE: The aim of this paper is to analyze the impact of prior breast cancer (BC) on mode of delivery and pregnancy-associated disorders. METHODS: A database from 262 German gynecological practices including 289,712 women between the ages of 18 and 45 with documented pregnancies between 2000 and 2014 was used to search for patients with a history of BC up to 10 years prior to pregnancy. A total of 165 patients with a history of BC were found and matched with 165 patients without a history of any cancer (1:1) by age, physician, obesity, and documented referral to a fertility center up to 12 months before the index pregnancy. The impact of prior BC on the mode of delivery and pregnancy-associated disorders was analyzed using Cox regression models. RESULTS: The mean maternal age at first visit was 34.6 years in both groups. The early and late pregnancy loss was significantly reduced (17.7 versus 29.9%, OR 0.50) and delivery of a live-born child more frequent (82.3 versus 70.1%, OR 2.00) in women who had had BC than in controls. Furthermore, preterm contractions without preterm birth were less frequent in women with BC compared to controls (9.2 versus 18.9%, OR 0.43). No significant differences were found for other pregnancy complications, such as suspected fetal growth restriction, genito-urinary infections, fetal malpresentation, gestational diabetes, pre-eclampsia, or breastfeeding issues. CONCLUSIONS: Based on the decreased rate of early and late pregnancy loss and the absence of significant differences in most documented pregnancy-associated disorders, women with the previous BC can be assured of the possibility of a good outcome on a subsequent pregnancy.
PURPOSE: The aim of this paper is to analyze the impact of prior breast cancer (BC) on mode of delivery and pregnancy-associated disorders. METHODS: A database from 262 German gynecological practices including 289,712 women between the ages of 18 and 45 with documented pregnancies between 2000 and 2014 was used to search for patients with a history of BC up to 10 years prior to pregnancy. A total of 165 patients with a history of BC were found and matched with 165 patients without a history of any cancer (1:1) by age, physician, obesity, and documented referral to a fertility center up to 12 months before the index pregnancy. The impact of prior BC on the mode of delivery and pregnancy-associated disorders was analyzed using Cox regression models. RESULTS: The mean maternal age at first visit was 34.6 years in both groups. The early and late pregnancy loss was significantly reduced (17.7 versus 29.9%, OR 0.50) and delivery of a live-born child more frequent (82.3 versus 70.1%, OR 2.00) in women who had had BC than in controls. Furthermore, preterm contractions without preterm birth were less frequent in women with BC compared to controls (9.2 versus 18.9%, OR 0.43). No significant differences were found for other pregnancy complications, such as suspected fetal growth restriction, genito-urinary infections, fetal malpresentation, gestational diabetes, pre-eclampsia, or breastfeeding issues. CONCLUSIONS: Based on the decreased rate of early and late pregnancy loss and the absence of significant differences in most documented pregnancy-associated disorders, women with the previous BC can be assured of the possibility of a good outcome on a subsequent pregnancy.
Entities:
Keywords:
Breast cancer; Mode of delivery; Pregnancy; Pregnancy-associated disorders
Authors: Beth A Mueller; Michael S Simon; Dennis Deapen; Aruna Kamineni; Kathleen E Malone; Janet R Daling Journal: Cancer Date: 2003-09-15 Impact factor: 6.860
Authors: L Mignot; F Morvan; J Berdah; D Querleu; J C Laurent; M Verhaeghe; F Fontaine; J L Marin; A Gorins; M Marty Journal: Presse Med Date: 1986-11-08 Impact factor: 1.228
Authors: Rashmi Verma; Ruth E Foster; Kieran Horgan; Katherine Mounsey; Helen Nixon; Natuley Smalle; Thomas A Hughes; Clive R D Carter Journal: Breast Cancer Res Date: 2016-01-26 Impact factor: 6.466
Authors: Anne-Lotte L F van der Kooi; David H Brewster; Rachael Wood; Sian Nowell; Colin Fischbacher; Marry M van den Heuvel-Eibrink; Joop S E Laven; W Hamish B Wallace; Richard A Anderson Journal: PLoS One Date: 2018-08-23 Impact factor: 3.240
Authors: Maria Vittoria Dieci; Cristina Ghiotto; Caterina Barbieri; Gaia Griguolo; Carlo Saccardi; Michele Gangemi; Alfonso Pluchinotta; Elisabetta Di Liso; Carlo Alberto Giorgi; Tommaso Giarratano; Giulia Tasca; Grazia Vernaci; Giovanni Faggioni; Pierfranco Conte; Valentina Guarneri Journal: J Womens Health (Larchmt) Date: 2018-07-02 Impact factor: 2.681